| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation Date | 2016-05-26 05:50:40 UTC |
|---|
| Update Date | 2016-11-09 01:21:19 UTC |
|---|
| Accession Number | CHEM035520 |
|---|
| Identification |
|---|
| Common Name | Triphosphate(5-) |
|---|
| Class | Small Molecule |
|---|
| Description | Used as water softener, peptizing agent, emulsifier & dispersing agent; ingredient of cleansers; meat preservative. |
|---|
| Contaminant Sources | |
|---|
| Contaminant Type | Not Available |
|---|
| Chemical Structure | |
|---|
| Synonyms | | Value | Source |
|---|
| Acide triphosphorique | ChEBI | | Catena-triphosphoric acid | ChEBI | | H5P3O10 | ChEBI | | Inorganic triphosphate | ChEBI | | Triphosphorsaeure | ChEBI | | Tripolyphosphoric acid | ChEBI | | Catena-triphosphate | Generator | | Inorganic triphosphoric acid | Generator | | Tripolyphosphate | Generator | | Triphosphoric acid | Generator | | (Phosphate)N | HMDB | | (Phosphate)n+1 | HMDB | | (Phosphate)N-1 | HMDB | | Bis(dihydroxidodioxidophosphato)hydroxidooxidophosphorus | HMDB | | Bis(phosphonooxy)phosphinic acid | HMDB | | DAD | HMDB | | DCT | HMDB | | DGT | HMDB | | Diphosphono hydrogen phosphate | HMDB | | DTP | HMDB | | GTP | HMDB | | Inorganic open chain tripolyphosphate | HMDB | | Triphospate | HMDB | | Triphosphate analogs | HMDB | | TTP | HMDB | | Sodium triphosphate | HMDB | | Tetrasodium tripolyphosphate | HMDB | | Triphosphoric acid, 99TC-labeled CPD | HMDB | | Triphosphoric acid, pentasodium salt | HMDB | | Triphosphoric acid, sodium salt | HMDB | | Potassium triphosphate | HMDB | | Sodium tripolyphosphate anhydrous | HMDB | | Triphosphoric acid, pentapotassium salt | HMDB | | Triphosphoric acid, sodium, potassium salt | HMDB | | Pentapotassium triphosphate | HMDB | | Sodium tripolyphosphate | HMDB | | PPPi | HMDB | | TRIphosphATE | ChEBI |
|
|---|
| Chemical Formula | O10P3 |
|---|
| Average Molecular Mass | 252.915 g/mol |
|---|
| Monoisotopic Mass | 252.870 g/mol |
|---|
| CAS Registry Number | 14127-68-5 |
|---|
| IUPAC Name | {[hydroxy(phosphonooxy)phosphoryl]oxy}phosphonic acid |
|---|
| Traditional Name | tripolyphosphate |
|---|
| SMILES | [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O |
|---|
| InChI Identifier | InChI=1S/H5O10P3/c1-11(2,3)9-13(7,8)10-12(4,5)6/h(H,7,8)(H2,1,2,3)(H2,4,5,6)/p-5 |
|---|
| InChI Key | UNXRWKVEANCORM-UHFFFAOYSA-I |
|---|
| Chemical Taxonomy |
|---|
| Description | belongs to the class of inorganic compounds known as non-metal phosphates. These are inorganic non-metallic compounds containing a phosphate as its largest oxoanion. |
|---|
| Kingdom | Inorganic compounds |
|---|
| Super Class | Homogeneous non-metal compounds |
|---|
| Class | Non-metal oxoanionic compounds |
|---|
| Sub Class | Non-metal phosphates |
|---|
| Direct Parent | Non-metal phosphates |
|---|
| Alternative Parents | |
|---|
| Substituents | - Non-metal phosphate
- Inorganic oxide
|
|---|
| Molecular Framework | Not Available |
|---|
| External Descriptors | |
|---|
| Biological Properties |
|---|
| Status | Detected and Not Quantified |
|---|
| Origin | Not Available |
|---|
| Cellular Locations | Not Available |
|---|
| Biofluid Locations | Not Available |
|---|
| Tissue Locations | Not Available |
|---|
| Pathways | Not Available |
|---|
| Applications | Not Available |
|---|
| Biological Roles | Not Available |
|---|
| Chemical Roles | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Appearance | Not Available |
|---|
| Experimental Properties | | Property | Value |
|---|
| Melting Point | Not Available | | Boiling Point | Not Available | | Solubility | Not Available |
|
|---|
| Predicted Properties | |
|---|
| Spectra |
|---|
| Spectra | | Spectrum Type | Description | Splash Key | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-0002-9520000000-e90a8c73374acf7bc122 | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0a6r-2690000000-673654046903650b7152 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03fs-5930000000-5eb4974ca8fed7558024 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-01qa-9500000000-b2404c5ea6e713839384 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0a4i-0090000000-7ab59c02dffe21b7a604 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-056r-9270000000-61dc72f8bf5e400f3882 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-004i-9000000000-6a7c993cb33cf4d5fedd | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0a4i-0090000000-db0b792e00f5267b0429 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0a6r-4690000000-1c8ad94ae184a8e58b61 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0002-9000000000-9afb7f62828d4245d383 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0a4i-0390000000-05444cfee24772b7b3b2 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0a4i-0900000000-2eca580fe4fd0b82d8a6 | Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0a4i-0900000000-2e0c12969f0c2680414e | Spectrum |
|
|---|
| Toxicity Profile |
|---|
| Route of Exposure | Not Available |
|---|
| Mechanism of Toxicity | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Toxicity Values | Not Available |
|---|
| Lethal Dose | Not Available |
|---|
| Carcinogenicity (IARC Classification) | Not Available |
|---|
| Uses/Sources | Not Available |
|---|
| Minimum Risk Level | Not Available |
|---|
| Health Effects | Not Available |
|---|
| Symptoms | Not Available |
|---|
| Treatment | Not Available |
|---|
| Concentrations |
|---|
| Not Available |
|---|
| External Links |
|---|
| DrugBank ID | DB03896 |
|---|
| HMDB ID | HMDB0003379 |
|---|
| FooDB ID | FDB028913 |
|---|
| Phenol Explorer ID | Not Available |
|---|
| KNApSAcK ID | Not Available |
|---|
| BiGG ID | Not Available |
|---|
| BioCyc ID | Not Available |
|---|
| METLIN ID | Not Available |
|---|
| PDB ID | Not Available |
|---|
| Wikipedia Link | Polyphosphate |
|---|
| Chemspider ID | 958 |
|---|
| ChEBI ID | 39949 |
|---|
| PubChem Compound ID | 983 |
|---|
| Kegg Compound ID | C02174 |
|---|
| YMDB ID | YMDB00844 |
|---|
| ECMDB ID | ECMDB03379 |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| MSDS | Not Available |
|---|
| General References | | 1. Tsuhako, Mitsutomo; Sueyoshi, Chiyoko; Miyajima, Tohru; Ohashi, Shigeru; Nariai, Hiroyuki; Motooka, Itaru. The reaction of cyclo-triphosphate with ethanolamines. Bulletin of the Chemical Society of Japan (1986), 59(10), 3091-5. | | 2. Cseri J, Szappanos H, Szigeti GP, Csernatony Z, Kovacs L, Csernoch L: A purinergic signal transduction pathway in mammalian skeletal muscle cells in culture. Pflugers Arch. 2002 Mar;443(5-6):731-8. Epub 2001 Dec 4. | | 3. Pelleg A, Schulman ES: Adenosine 5'-triphosphate axis in obstructive airway diseases. Am J Ther. 2002 Sep-Oct;9(5):454-64. | | 4. Ding Z, Kim S, Dorsam RT, Jin J, Kunapuli SP: Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270. Blood. 2003 May 15;101(10):3908-14. Epub 2003 Jan 30. | | 5. Feng YH, Wang L, Wang Q, Li X, Zeng R, Gorodeski GI: ATP stimulates GRK-3 phosphorylation and beta-arrestin-2-dependent internalization of P2X7 receptor. Am J Physiol Cell Physiol. 2005 Jun;288(6):C1342-56. Epub 2005 Feb 23. | | 6. Smits P, Bijlstra PJ, Russel FG, Lutterman JA, Thien T: Cardiovascular effects of sulphonylurea derivatives. Diabetes Res Clin Pract. 1996 Jul;31 Suppl:S55-9. | | 7. Sawynok J, Liu XJ: Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol. 2003 Apr;69(5):313-40. | | 8. Gerasimovskaya EV, Ahmad S, White CW, Jones PL, Carpenter TC, Stenmark KR: Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth. Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor. J Biol Chem. 2002 Nov 22;277(47):44638-50. Epub 2002 Sep 18. | | 9. Burnstock G: Noradrenaline and ATP: cotransmitters and neuromodulators. J Physiol Pharmacol. 1995 Dec;46(4):365-84. | | 10. Podust VN, Korobeinicheva TO, Nevinskii GA, Rikhter VA, Abramova TI, Lavrik OI: [Template-primer-dependent inactivation of DNA polymerase alpha from human placenta by 2',3'-epoxyadenosine-5'-triphosphate]. Bioorg Khim. 1990 Feb;16(2):226-35. | | 11. Valdecantos P, Briones R, Moya P, Germain A, Huidobro-Toro JP: Pharmacological identification of P2X1, P2X4 and P2X7 nucleotide receptors in the smooth muscles of human umbilical cord and chorionic blood vessels. Placenta. 2003 Jan;24(1):17-26. | | 12. Bijlstra PJ, Russel FG, Thien T, Lutterman JA, Smits P: Effects of tolbutamide on vascular ATP-sensitive potassium channels in humans. Comparison with literature data on glibenclamide and glimepiride. Horm Metab Res. 1996 Sep;28(9):512-6. | | 13. Lavoie EG, Kukulski F, Levesque SA, Lecka J, Sevigny J: Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-3. Biochem Pharmacol. 2004 May 15;67(10):1917-26. | | 14. Banks FC, Knight GE, Calvert RC, Turmaine M, Thompson CS, Mikhailidis DP, Morgan RJ, Burnstock G: Smooth muscle and purinergic contraction of the human, rabbit, rat, and mouse testicular capsule. Biol Reprod. 2006 Mar;74(3):473-80. Epub 2005 Nov 9. |
|
|---|